3-Methylpyridine (CAS NO : 108-99-6)

3-Methylpyridine (CAS 108-99-6), also known as beta picoline, is a critical heterocyclic intermediate in the global pyridine derivatives market, which is projected to reach a valuation of USD 2.64 billion by 2034. The beta picoline segment currently holds over a 25% revenue share, largely driven by its indispensable role as the primary precursor for the industrial synthesis of niacin (vitamin B3), with over 90% of global niacin production—exceeding 55,000 metric tons—derived from the catalytic oxidation of this compound. Beyond nutritional applications, 3-methylpyridine is seeing significant technical expansion as a versatile ligand in coordination chemistry and as a mediator in vanadium redox flow batteries, where it has demonstrated the ability to enhance electron transfer efficiency by up to 22%. Furthermore, its application in the synthesis of advanced pyridine insecticides and pharmaceutical agents for central nervous system disorders underscores its strategic importance in high-value specialty chemical portfolios. As a globally established 3-Methylpyridine supplier with 98% purity. We ensure dependable supply, consistent quality, and complete regulatory documentation, including 3-Methylpyridine CoA and 3-Methylpyridine TDS across all grades. Beyond supply, we support partners through the entire product lifecycle from route scouting, process and formulation development, and analytical method development to scale-up, process optimisation, and pilot-to-commercial manufacturing. Our teams also assist with GMP-compliant quality assurance, regulatory documentation, and global supply chain and logistics coordination.